Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vogt-Koyanagi-Harada syndrome - current perspectives.
Baltmr A, Lightman S, Tomkins-Netzer O. Baltmr A, et al. Clin Ophthalmol. 2016 Nov 24;10:2345-2361. doi: 10.2147/OPTH.S94866. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27932857 Free PMC article. Review.
Neuroprotection in glaucoma - Is there a future role?
Baltmr A, Duggan J, Nizari S, Salt TE, Cordeiro MF. Baltmr A, et al. Exp Eye Res. 2010 Nov;91(5):554-66. doi: 10.1016/j.exer.2010.08.009. Epub 2010 Aug 26. Exp Eye Res. 2010. PMID: 20800593 Review.
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk; RECOVERY Collaborative Group. RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk, et al. Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13. Lancet. 2023. PMID: 37060915 Free PMC article. Clinical Trial.
Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.
von Krusenstiern L, Liu J, Liao E, Gow JA, Chen G, Ong T, Lotery AJ, Jalil A, Lam BL, MacLaren RE; XIRIUS Part 1 Study GroupXOLARIS Study Group. von Krusenstiern L, et al. JAMA Ophthalmol. 2023 Mar 1;141(3):275-283. doi: 10.1001/jamaophthalmol.2022.6254. JAMA Ophthalmol. 2023. PMID: 36757689 Free PMC article. Clinical Trial.